A Functional MRI Study on Erenumab Treatment Effects in Episodic Migraine Patients

NCT03977649 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

62

Enrollment

INDUSTRY

Sponsor class

Conditions

Migraine Disorders

Interventions

DRUG: erenumab
DRUG: placebo

Sponsor

Novartis Pharmaceuticals